R-7089

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameR-7089
Drug Alias NameR-7089RG-7089
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionNeuropeptide Y receptor type 2 agonists
TargetsNeuropeptide Y receptor type 2
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesF. Hoffmann-La Roche Ltd
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A